Tarsus Pharmaceuticals
The Senior Director, Technical Operations at Tarsus Pharmaceuticals provides strategic leadership and oversight of drug product manufacturing and external CDMO operations from late-stage development through commercialization, ensuring reliable supply and scalability. The role partners cross‑functionally with Pharmaceutical Sciences, Analytical Development, Supply Chain, Regulatory, and Quality to align CMC strategy, manage high‑risk issues, and drive operational excellence.
Tarsus Pharmaceuticals is a biopharmaceutical company focused on developing and commercializing novel therapies for diseases with high unmet need, with a primary focus on eye care. The company markets XDEMVY® (lotilaner ophthalmic solution) 0.25%, the first and only FDA-approved treatment for Demodex blepharitis, and has a pipeline targeting conditions such as ocular rosacea and Lyme disease.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Tarsus Pharmaceuticals.
Director, Pharmaceutical Development
Nurix
Director, Process Sciences
CytomX Therapeutics
Head of Drug Product Development
Ironwood Pharmaceuticals
Director, Technical (CMC) Project Management
Structure Therapeutics
Director, Analytical Development (Small Molecule)
Structure Therapeutics
AS&T Principal Scientist - CGT & Biologics
Vertex